529 related articles for article (PubMed ID: 27882487)
21. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
[TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery.
Banizs AB; Huang T; Dryden K; Berr SS; Stone JR; Nakamoto RK; Shi W; He J
Int J Nanomedicine; 2014; 9():4223-30. PubMed ID: 25214786
[TBL] [Abstract][Full Text] [Related]
23. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.
Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP
J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079
[TBL] [Abstract][Full Text] [Related]
24. [Small interfering RNA (siRNA) targeting vascular endothelial growth factor inhibits vascular leakage in brain of rats exposed to high altitude].
Deng ZK; Qian GS; Cheng SY; Wu J
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2639-43. PubMed ID: 20137683
[TBL] [Abstract][Full Text] [Related]
25. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
[TBL] [Abstract][Full Text] [Related]
26. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
[TBL] [Abstract][Full Text] [Related]
28. Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma.
Yi N; Oh B; Kim HA; Lee M
J Drug Target; 2014 Feb; 22(2):156-64. PubMed ID: 24219243
[TBL] [Abstract][Full Text] [Related]
29. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.
Xia CF; Zhang Y; Zhang Y; Boado RJ; Pardridge WM
Pharm Res; 2007 Dec; 24(12):2309-16. PubMed ID: 17926121
[TBL] [Abstract][Full Text] [Related]
30. Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases.
Jiang J; Lu Y; Chu J; Zhang X; Xu C; Liu S; Wan Z; Wang J; Zhang L; Liu K; Liu Z; Yang A; Ren X; Zhang R
J Nanobiotechnology; 2024 Apr; 22(1):159. PubMed ID: 38589859
[TBL] [Abstract][Full Text] [Related]
31. SELEX-Based Screening of Exosome-Tropic RNA.
Yamashita T; Shinotsuka H; Takahashi Y; Kato K; Nishikawa M; Takakura Y
Biol Pharm Bull; 2017; 40(12):2140-2145. PubMed ID: 29199238
[TBL] [Abstract][Full Text] [Related]
32. Delivery of Small Interfering RNAs to Cells via Exosomes.
Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
[TBL] [Abstract][Full Text] [Related]
33. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
34. Exosome-mediated small interfering RNA delivery inhibits aberrant osteoblast differentiation in Apert syndrome model mice.
Myo AC; Kobayashi Y; Niki Y; Kamimoto H; Moriyama K
Arch Oral Biol; 2023 Sep; 153():105753. PubMed ID: 37348363
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
[TBL] [Abstract][Full Text] [Related]
36. Astrocyte-Derived Pentraxin 3 Supports Blood-Brain Barrier Integrity Under Acute Phase of Stroke.
Shindo A; Maki T; Mandeville ET; Liang AC; Egawa N; Itoh K; Itoh N; Borlongan M; Holder JC; Chuang TT; McNeish JD; Tomimoto H; Lok J; Lo EH; Arai K
Stroke; 2016 Apr; 47(4):1094-100. PubMed ID: 26965847
[TBL] [Abstract][Full Text] [Related]
37. WDR81 Gene Silencing Can Reduce Exosome Levels in Human U87-MG Glioblastoma Cells.
Tadayoni Nia A; Bazi Z; Khosravi A; Oladnabi M
J Mol Neurosci; 2021 Aug; 71(8):1696-1702. PubMed ID: 33954857
[TBL] [Abstract][Full Text] [Related]
38. Exosomes for targeted siRNA delivery across biological barriers.
El Andaloussi S; Lakhal S; Mäger I; Wood MJ
Adv Drug Deliv Rev; 2013 Mar; 65(3):391-7. PubMed ID: 22921840
[TBL] [Abstract][Full Text] [Related]
39. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
[TBL] [Abstract][Full Text] [Related]
40. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison.
Wu JY; Li YJ; Hu XB; Huang S; Luo S; Tang T; Xiang DX
J Control Release; 2021 Aug; 336():510-521. PubMed ID: 34237399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
